We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

CRISPR and Genome Editing – News and Features

News

Mouse Study Reveals Stem Cell Capability in Brain Tissue Repair

UCSF scientists determine that adult stem cells in the mouse brain have a built-in mechanism that allows the cells to participate in the repair of damaged tissue.
News

Study Shows Genetically Modified Cells Attack Tumors

St. Jude researchers have treated tumors with genetically modified cells that sought out and activated a chemotherapy drug placed directly at the cancer cells.
News

Invitrogen and Blue Heron Biotechnology Enter into Strategic Development and Distribution Relationship

Invitrogen will invest in Blue Heron in exchange for worldwide rights to distribute Blue Heron's custom gene synthesis services.
News

ARTEMIS signs Agreement with Merck for Generation of Genetically Engineered In-Vivo RNAi Mouse Models

The agreement represents an approach to gene function analysis using shRNA knock down in genetically engineered mice as models for human biology.
News

Adult Stem Cells Show Potential for Diabetes Solution

Adult stem cells increase insulin production in mice with type 2 diabetes say Tulane University gene therapy researchers.
News

Micro Molecules Contribute Mightily to Heart Problem

Tiny bits of RNA play a large role in causing enlargement of the heart.
News

Micro Molecules Contribute Mightily to Heart Problem

Researchers reports that manipulating micro RNAs might be a way to treat heart disease.
News

Adult Stem Cells Show Potential for Diabetes Solution

Tulane University researchers have said that adult stem cells increase insulin production in mice with type 2 diabetes.
News

King's Scientists Submit Stem Cell Research Licence Application

The licence, if granted, will boost research into neurological diseases.
News

Targeted Genetics Receives Patent for Enhanced Core Technology Including Expressed RNA

The patent describes the use of AAV vectors that are efficient for expression of therapeutic genetic constructs.
Advertisement